Generic Drug Analysis & Statistics, August 2013 (p4)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

91-120 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Generics in the Netherlands, MarketLine

Generics in the Netherlands, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The ...

  • Industries : Generic Drug
  • Countries : Netherlands
Generics in Canada, MarketLine

Generics in Canada, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : Canada
Global Generics, MarketLine

Global Generics, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug
  • Countries : World
Biologics and Biosimilars World Markets

Biologics and Biosimilars World Markets

  • $ 3 400
  • Industry report
  • August 2013
  • by TriMark Publications

Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating ...

  • Industries : Pharmaceutical, Biotechnology, Drug and Medication, Biopharmaceutical
  • Countries : United States, North America, World
Sigma International General Medical Apparatus L.L.C. - Medical Equipment - Deals and Alliances Profile

Sigma International General Medical Apparatus L.L.C. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Sigma International General Medical Apparatus L.L.C. (Sigma) is a manufacturer of large volume infusion pumps. It is a part of Baxter International Inc. The company offers infusion systems that ...

EMS SA in Consumer Health (Brazil)

EMS SA in Consumer Health (Brazil)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

EMS plans to reach the leading position amongst all the consumer health companies in the country. In order to accomplish this goal, it is expected to continue to invest in generics, by launching new products ...

  • Industries : Drug and Medication
  • Countries : South Africa, Saudi Arabia
Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023

  • $ 2 633
  • Industry report
  • July 2013
  • by Visiongain

Report Details Generics companies - assess products, developments, and revenue prospects What does the future hold for makers of generic drugs? Visiongain's updated report shows you their prospects to ...

  • Industries : Generic Drug
Cancer Generics Market Outlook 2017

Cancer Generics Market Outlook 2017

  • $ 1 000
  • Industry report
  • July 2013
  • by RNCOS

The National Cancer Institute has stated that almost half of the population born today will be diagnosed with cancer at some point during their lifetime. With global cancer incidence rising to almost 13 ...

  • Industries : Pharmaceutical, Pathology, Drug and Medication
  • Countries : World
Biogaran, Laboratoires in Consumer Health (France)

Biogaran, Laboratoires in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Laboratoires Biogaran is expected to maintain its focus on its core business activities: the development, manufacturing, marketing and distribution of generics. With the reinforcement of “Third party ...

  • Industries : Generic Drug, Healthcare
  • Countries : France
Biosimilar Defensive Plays – Assessing the options

Biosimilar Defensive Plays – Assessing the options

  • $ 495
  • Industry report
  • June 2013
  • by Firstword Pharma

Although biological therapeutics have developed into an increasingly valuable segment of the pharmaceutical market, the commercial impact of biosimilar products has, to date, been fairly insignificant. ...

  • Industries : Generic Drug
  • Countries : United States
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

  • $ 2 995
  • Industry report
  • May 2013
  • by Global Data

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalData’s "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, ...

  • Industries : Generic Drug
  • Countries : Europe, India, World, China
Alzheimer's Drugs Market, 2012 - 2017

Alzheimer's Drugs Market, 2012 - 2017

  • $ 1 699
  • Industry report
  • May 2013
  • by Roots Analysis Private Ltd.

Alzheimer’s disease is a neurodegenerative disease of the brain which leads to loss of memory and cognitive functions. With ageing world population, the number of patients suffering from Alzheimer’s ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Europe, World, Japan
Orifarm A/S in Consumer Health (Denmark)

Orifarm A/S in Consumer Health (Denmark)

  • $ 153
  • Company report
  • May 2013
  • by Euromonitor International

Orifarm A/S is a fast growing supplier of parallel imported and generic pharmaceuticals. Orifarm’s strategic focus is to strengthen its position as the leading supplier of parallel imports and generic ...

  • Industries : Pharmaceutical, Healthcare, Generic Drug
  • Countries : Denmark
Biosimilars And Follow-On Biologics: World Market 2013-2023

Biosimilars And Follow-On Biologics: World Market 2013-2023

  • $ 2 633
  • Industry report
  • April 2013
  • by Visiongain

Report Details Biosimilar drugs - discover trends and areas with highest revenue potential Do you want to find the sales potential of biosimilars? Visiongain's updated report gives you revenue predictions ...

  • Industries : Biopharmaceutical
  • Countries : Europe, World
Sigma International General Medical Apparatus LLC - Medical Equipment - Deals and Alliances Profile

Sigma International General Medical Apparatus LLC - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2013
  • by Global Data

Summary SIGMA International General Medical Apparatus, LLC is a manufacturer of large volume infusion pumps, with a mission to improve patient safety, and prevent adverse drug events at the bedside through ...

Branded Generics: Strategies and Tactics for Winning in Latin America

Branded Generics: Strategies and Tactics for Winning in Latin America

  • $ 1 995
  • Industry report
  • April 2013
  • by Firstword Pharma

Introduction It’s a $66 billion market—and getting bigger every year. The time is ripe for action. Yet for all the appeal and potential returns of investing in Latin America’s burgeoning branded ...

  • Industries : Generic Drug
  • Countries : United States
PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013

PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013 Summary "PharmaLeaders: Generic Manufacturers Benchmark Report ...

  • Industries : Generic Drug
PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013

  • $ 2 995
  • Industry report
  • March 2013
  • by Global Data

PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 Summary GlobalData’s "PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013" report, provides ...

  • Industries : Generic Drug
  • Countries : World, India
Biosimilars in Emerging Markets

Biosimilars in Emerging Markets

  • $ 665
  • Industry report
  • March 2013
  • by Firstword Pharma

What are the implications for regulators, biosimilar companies and branded manufacturers? There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway to developing ...

  • Industries : Generic Drug
  • Countries : Brazil, South Korea
The 2013-2018 Outlook for Over-The-Counter Generic Drugs in the United States

The 2013-2018 Outlook for Over-The-Counter Generic Drugs in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for over-the-counte ...

  • Industries : Generic Drug
  • Countries : United States
The 2013-2018 Outlook for Generic Drugs in the United States

The 2013-2018 Outlook for Generic Drugs in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for generic drugs ...

  • Industries : Generic Drug
  • Countries : United States
The 2013-2018 Outlook for Generic Prescription Drugs in the United States

The 2013-2018 Outlook for Generic Prescription Drugs in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for generic prescription ...

  • Industries : Generic Drug
  • Countries : United States
The 2013-2018 Outlook for Over-The-Counter Generic Drugs in Japan

The 2013-2018 Outlook for Over-The-Counter Generic Drugs in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for over-the-counte ...

  • Industries : Generic Drug
  • Countries : Japan
The 2013-2018 Outlook for Generic Drugs in Japan

The 2013-2018 Outlook for Generic Drugs in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for generic drugs ...

  • Industries : Generic Drug
  • Countries : Japan
The 2013-2018 Outlook for Generic Prescription Drugs in Japan

The 2013-2018 Outlook for Generic Prescription Drugs in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for generic prescription ...

  • Industries : Generic Drug
  • Countries : Japan
The 2013-2018 World Outlook for Generic Drugs

The 2013-2018 World Outlook for Generic Drugs

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for generic drugs across ...

  • Industries : Generic Drug
The 2013-2018 World Outlook for Generic Prescription Drugs

The 2013-2018 World Outlook for Generic Prescription Drugs

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for generic prescription ...

  • Industries : Generic Drug
The 2013-2018 World Outlook for Over-The-Counter Generic Drugs

The 2013-2018 World Outlook for Over-The-Counter Generic Drugs

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the world outlook for over-the-counter generic drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Generic Drug
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

  • $ 3 500
  • Industry report
  • December 2012
  • by GBI Research

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence ...

  • Industries : Generic Drug
  • Countries : Europe
Global Biosimilars Market - Products, Applications and Regulations

Global Biosimilars Market - Products, Applications and Regulations

  • $ 4 320
  • Industry report
  • November 2012
  • by Industry Experts

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies’ ...

  • Industries : Biopharmaceutical, Biotechnology, Biological Therapy
  • Countries : Europe, World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.